14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:SGYP
Delisted

Synergy Pharmaceuticals Stock Price (Quote)

$0.0064
+0 (+0%)
At Close: Sep 17, 2019

Range Low Price High Price Comment
30 days $5.34 $19.02 Tuesday, 17th Sep 2019 SGYP stock ended at $0.0064. During the day the stock fluctuated 0% from a day low at $0.0064 to a day high of $0.0064.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Synergy Pharmaceuticals prices

Date Open High Low Close Volume
Sep 17, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Sep 16, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Sep 13, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Sep 12, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Sep 11, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Sep 10, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Sep 09, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Sep 06, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Sep 05, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Sep 04, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Sep 03, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Aug 30, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Aug 29, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Aug 28, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Aug 27, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Aug 26, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Aug 23, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Aug 22, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Aug 21, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Aug 20, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Aug 19, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Aug 16, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Aug 15, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Aug 14, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Aug 13, 2019 $0.0064 $0.0064 $0.0064 $0.0064 0
Click to get the best stock tips daily for free!

About Synergy Pharmaceuticals

Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase III clinical trials to treat chronic idiopathic constipation GI disorders; and for the treatment of constipation-predominant irritable bowel syndrome GI disorders. The company is also developing SP-333,... SGYP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT